The potential of gut-microbiota-targeted reprogramming interventions designed to prevent the onset and progression of cardiovascular diseases

FHS
August 28, 2023
11:37 am

Researchers discuss the potential of probiotic- and prebiotic-based interventions for managing cardiovascular diseases.

Opinion | ‘You Can Create Some Scary Sounding Headlines’: What We Heard This Week

“If you only report on the nurses leaving, and don’t account for those who are coming in, you can create some scary sounding headlines.” —

February 19, 2024

UK’s NICE recommends AbbVie’s Aquipta to treat migraines – Pharmaceutical Technology

Share this article According to GlobalData, the migraine drugs market is set to be worth $18.6bn in 2030 globally. Credit: Krakenimages.com via Shutterstock. The National

April 11, 2024

Atara’s T cell programmes hit with clinical hold after third-party site woes – Pharmaceutical Technology

Atara said it has discussed and agreed with the FDA “upon the actions necessary to release the clinical holds”. Image credit: Shutterstock / Lamar Belina.

January 22, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.